UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
iShares Russell 2000 Growth ETF
IWO
$14.9B
| $2.01M | ﹤0.01% |
+8,863
| New | +$2.03M |
|
1577
Herbalife
HLF
$1.21B
| $2.01M | ﹤0.01% |
124,720
+2,143
| +2% | +$37.9K |
|
1578
Myriad Genetics
MYGN
$311M
| $2.01M | ﹤0.01% |
86,407
+14,195
| +20% | +$288K |
|
1579
Jackson Financial
JXN
$8.83B
| $2M | ﹤0.01% |
53,482
-12,969
| -20% | -$533K |
|
1580
Standex International
SXI
$3.98B
| $2M | ﹤0.01% |
16,331
+871
| +6% | +$99.1K |
|
1581
Enterprise Financial Services Corp
EFSC
$2.38B
| $1.99M | ﹤0.01% |
44,693
-1,419
| -3% | -$72.6K |
|
1582
Travere Therapeutics
TVTX
$5.74B
| $1.99M | ﹤0.01% |
88,545
+24,967
| +39% | +$531K |
|
|
EVRI
1583
DELISTED
Everi Holdings
EVRI
| $1.98M | ﹤0.01% |
115,714
+12,043
| +12% | +$208K |
|
1584
FTAI Aviation
FTAI
$22.1B
| $1.98M | ﹤0.01% |
+70,955
| New | +$1.68M |
|
1585
OFG Bancorp
OFG
$2.2B
| $1.98M | ﹤0.01% |
79,503
+3,353
| +4% | +$93.8K |
|
|
RXDX
1586
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $1.98M | ﹤0.01% |
18,448
-76
| -0.4% | -$8.75K |
|
1587
BioCryst Pharmaceuticals
BCRX
$2.51B
| $1.97M | ﹤0.01% |
236,561
+32,861
| +16% | +$316K |
|
1588
Simmons First National
SFNC
$3.4B
| $1.97M | ﹤0.01% |
112,753
+8,190
| +8% | +$174K |
|
1589
Kennametal
KMT
$2.41B
| $1.97M | ﹤0.01% |
71,371
-2,151
| -3% | -$59.3K |
|
1590
Cheesecake Factory
CAKE
$5.53B
| $1.97M | ﹤0.01% |
56,160
+4,155
| +8% | +$155K |
|
|
LAZR
1591
DELISTED
Luminar Technologies
LAZR
| $1.96M | ﹤0.01% |
20,175
+8,369
| +71% | +$878K |
|
|
KYNB
1592
Kyntra Bio
KYNB
$28.2M
| $1.96M | ﹤0.01% |
4,203
+115
| +3% | +$60.8K |
|
1593
Cinemark Holdings
CNK
$4.38B
| $1.96M | ﹤0.01% |
132,501
-6,216
| -4% | -$75.4K |
|
1594
Hain Celestial
HAIN
$53.4M
| $1.96M | ﹤0.01% |
114,128
+4,170
| +4% | +$75.9K |
|
1595
Revolution Medicines
RVMD
$44.4B
| $1.96M | ﹤0.01% |
90,325
+27,424
| +44% | +$675K |
|
1596
PRA Group
PRAA
$723M
| $1.96M | ﹤0.01% |
50,213
-5,254
| -9% | -$206K |
|
1597
WaFd
WAFD
$2.76B
| $1.96M | ﹤0.01% |
64,924
+4,355
| +7% | +$147K |
|
1598
Schrodinger
SDGR
$1.4B
| $1.95M | ﹤0.01% |
74,220
+6,528
| +10% | +$155K |
|
1599
Dana Inc
DAN
$3.21B
| $1.95M | ﹤0.01% |
129,673
-23,301
| -15% | -$381K |
|
1600
Hilltop Holdings
HTH
$2.22B
| $1.95M | ﹤0.01% |
65,768
-4,838
| -7% | -$153K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.